Investment trust

RTW Biotech Opportunities Ord

ISIN
GG00BKTRRM22

How good is this fund, really?

See the rating in the app

About RTW Biotech Opportunities Ord

Biotechnology and medical technology are the sole sectors for this Guernsey closed-ended company, externally managed by RTW Investments, LP. It aims for positive absolute performance and long-term capital growth by backing firms that develop new drugs or medical devices, holding a diversified portfolio. The key information document puts exposure to the United States at 73% as of 31 March 2026. Shares were admitted to the London Stock Exchange in October 2019, and the company took its present name in June 2023, having been called RTW Venture Fund Limited. It has no fixed life. The risk indicator is 5 of 7, the recommended holding period is 5 years, and no capital protection is offered.

Watch this fund for free Add RTW Biotech Opportunities Ord to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy RTW Biotech Opportunities Ord — platforms and fees

Sold on 3 platforms we follow.

RTW Biotech Opportunities Ord — its category

Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.

Biotechnology funds →

Other funds